The purpose of this study is to better understand the interactions between the innate immune system, in particular eosinophils (EOS), and adipose tissue (AT) in human health and in disease states such as obesity and insulin resistance.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
4
endoscopic procedure for weight loss
Mayo Clinic in Arizona
Scottsdale, Arizona, United States
weight loss
total body weight
Time frame: at 30 days post-intervention
weight loss
total body weight
Time frame: at 60 days post-intervention
weight loss
total body weight
Time frame: at 90 days post-intervention
fat mass
% fat mass will be estimated by bioimpedence
Time frame: at 30 days post-intervention
fat mass
% fat mass will be estimated by bioimpedence
Time frame: at 60 days post-intervention
fat mass
% fat mass will be estimated by bioimpedence
Time frame: at 90 days post-intervention
AT-EOS content
subcutaneous fat biopsy will be processed to extract stromal vascular fraction (SVF) which will contain eosinophils. The SVF will be run trough flow cytometry to get an estimated count to be reported as a ratio over the total number of cells
Time frame: at baseline
AT-EOS content
subcutaneous fat biopsy will be processed to extract stromal vascular fraction (SVF) which will contain eosinophils. The SVF will be run trough flow cytometry to get an estimated count to be reported as a ratio over the total number of cells
Time frame: at 90 days post-intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
insulin sensitivity
mixed meal test
Time frame: at baseline and 90 days post-intervention
inflammation
Plasma will be isolated during fasting condition. MCP-1, TNFa, IL-4, IL-13, Leptin, adiponectin will be assessed via Multiplex ELISA
Time frame: at 30 days post-intervention
inflammation
Plasma will be isolated during fasting condition. MCP-1, TNFa, IL-4, IL-13, Leptin, adiponectin will be assessed via Multiplex ELISA
Time frame: at 60 days post-intervention
inflammation
Plasma will be isolated during fasting condition. MCP-1, TNFa, IL-4, IL-13, Leptin, adiponectin will be assessed via Multiplex ELISA
Time frame: at 90 days post-intervention
adipose tissue inflammation
subcutaneous fat biopsy will be processed to obtain mRNA. mRNA levels for MCP-1, TNFa, IL-4, IL-13, Leptin, adiponectin gene will be assessed via qPCR
Time frame: at baseline
adipose tissue inflammation
subcutaneous fat biopsy will be processed to obtain mRNA. mRNA levels for MCP-1, TNFa, IL-4, IL-13, Leptin, adiponectin gene will be assessed via qPCR
Time frame: at 90 days post-intervention